Communication FDA Nursing Homes 
PharmaShots
MAY 10, 2023
On Oct 2022, Philips’s AI-enabled MRCAT Head and Neck received the FDA 510(K) approval from the US FDA for the treatment of Head and Neck Cancer. The company provides these products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and patients.
Pharmaceutical Technology
MAY 1, 2023
After a US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) Advisory Committee (AdCom) meeting in March 2023 voted unanimously in support of GSK’s respiratory syncytial virus vaccine, the odds for an approval have increased. Even in LICs, they do yearly checks or catch up campaigns.
Expert insights. Personalized for you.
40 
Let's personalize your content